ReviewFrontiers in pharmacology2024

N-terminal domain of androgen receptor is a major therapeutic barrier and potential pharmacological target for treating castration resistant prostate cancer: a comprehensive review.

Ye Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.